摘要
甲状腺癌是常见的内分泌恶性肿瘤,传统上分为甲状腺分化性癌、甲状腺未分化癌和甲状腺髓样癌,分化性癌又分为乳头状癌和滤泡型腺癌[1],甲状腺未分化癌比较少见且预后极差,甲状腺髓样癌来源于甲状腺滤泡旁细胞(C细胞),属于神经内分泌肿瘤中的一种,在多发性2型内分泌瘤中约25%的患者伴有甲状腺髓样癌[2]。
出处
《实用医学杂志》
CAS
北大核心
2009年第22期3900-3902,共3页
The Journal of Practical Medicine
参考文献25
-
1Liu J,Singh B,Tallini G,et al.Follicular variant of papillary thyroid carcinoma:a clinicopathologic study of a problematic entity[J].Cancer,2006,107(6):1255-1264.
-
2Brauckhoff M,Lorenz K,Ukkat J,et al.Medullary thyroid carcinoma[J].Scand J Surg,2004,93(4):249-260.
-
3Lee T I,Yang H J,Lin S Y,et al.The accuracy of fi ne-needle aspiration biopsy and frozen section in patients with thyroid cancer[J].Thyroid,2002,12(7):619-626.
-
4Baloch Z W,Fleisher S,LiVolsi V A,et al.Diagnosis of"follicular neoplasm":a gray zone in thyroid fine-needle aspiration cytology[J].Diagn Cytopathol,2002,26(1):41-44.
-
5Alaedeen D I,Khiyami A,McHenry C R.Fine-needle aspiration biopsy specimen with a predominance of Hurthle ceils:a dilemma in the management of nodular thyroid disease[J].Surgery,2005,138(4):650-656.
-
6Laco J,Ryska A,Cáp J,Celakovsky P.Expression of galectin-3,cytokeratin 19,neural cell adhesion molecule and Ecadhedrin in certain variants of papillary thyroid carcinoma[J].Cesk Patol,2008,44(4):103-107.
-
7Semenov DIu,Pozharisskil K M,Boriskova M E,et al.Galectin-3 in diagnosis of thyroid cancer[J].Vopr Onkol,2008,54(3):321-323.
-
8Than T H,Swethadri G K,Wong J,et al.Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators[J].Singapore Med J,2008,49(4):333-338.
-
9Kopezynska E,Kwapisz J,Junik R,Tyrakowski T.Cellular tumor markers in thyroid cancer[J].Pol Merkur Lekarski,2007,22(130):295-299.
-
10Saussez S,Glinoer D,Chantrain G,et al.Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease[J].Thyroid,2008,18(7):705-712.
同被引文献45
-
1姚嘉艳,何乐建,周春菊.儿童甲状腺髓样癌1例[J].诊断病理学杂志,2006,13(4):301-301. 被引量:2
-
2王利,刘文玉,周桂芝.癌胚抗原在诊断肠癌及其他肿瘤中的应用[J].白求恩军医学院学报,2007,5(2):115-116. 被引量:4
-
3王化修,伍石华,蒙松年,杨华,张灿云,周秋爱.甲状腺髓样癌临床病理分析[J].临床肿瘤学杂志,2007,12(4):282-284. 被引量:2
-
4Colombo P, Locatelli F, Travaglini P. Useful and limits of the bio- chemical markers for the diagnosis of thyroid carcinoma [ J ]. Ann Ital Chir, 2006, 77(3): 209-214.
-
5Sanso GE, Domene HM, Garcia R. Very early detection of RET proto- oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C - cell malignant disease in asymptomatic carriers [ J ]. Cancer, 2002, 94 (2) : 323 - 330.
-
6Alaedeen DI, Khiyami A, McHenry CR. Fine - needle aspiration bi- opsy specimen with a predominance of Hurthle cells : a dilemma in the management of nodular thyroid disease [ J ]. Surgery, 2005, 138 (4) : 650 - 656.
-
7Houvras Y. Completing the Arc : Targeted Inhibition of RET in Medul- lary Thyroid Cancer[J]. J Clin Oncol, 2012, 30(2) : 200 -202.
-
8Iacobone M, Niccoli - Sire P, Sebag F, et al. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels [ J ]. World J Surg, 2002, 26(8): 886-890.
-
9Costante G, Meringolo D, Durante C, et al. Predictive value of ser- um calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nod- ules[J]. J Clin Endocrinol Metab, 2007, 92(2) : 450-455.
-
10VIRK RK,VAN DYKE AL,FINKELSTEIN A,et al.BRAF(V600E)mutation in papillary thyroid microcarcinoma:a genotype-phenotype correlation[J].Modern pathology,2012,27(2):161-165.
引证文献6
-
1薛声能,雷娟,李娜,徐明彤.降钙素和癌胚抗原联合检测在甲状腺髓样癌诊治中的意义[J].中国卫生检验杂志,2012,22(7):1620-1621. 被引量:17
-
2高福平,魏谨,马平.1例以CEA长期增高为首发表现的甲状腺髓样癌临床病理分析[J].医学理论与实践,2014,27(6):807-807. 被引量:1
-
3李爽,李茉,王森,丁国楠,刘洋,姜瑛.甲状腺髓样癌诊断的研究进展[J].中国实验诊断学,2014,18(11):1902-1904. 被引量:3
-
4李燕文,廖碧玲,曹天生.不同手术方式对治疗甲状腺微小乳头状癌的预后[J].广州医药,2016,47(5):42-44. 被引量:9
-
5王德平,郭长秀,王彤彤,关悦,孙毓晗.沙参麦冬汤联合碘[131I]化钠口服溶液对甲状腺癌术后患者的临床疗效[J].中成药,2019,41(6):1280-1284. 被引量:22
-
6王贝贝,张庆泉,王春雨,于伟,张芬,王小雨,李宇玥,潘永斌,周伟,李志芸.甲状腺髓样癌2例[J].中国医学文摘(耳鼻咽喉科学),2019,34(4):316-317. 被引量:1
二级引证文献53
-
1魏勇,管步高,万本海.渐进性肌肉放松训练联合碘131对甲状腺癌患者的影响[J].心理月刊,2022(7):69-71. 被引量:1
-
2唐光敏.以腹泻首发甲状腺髓样癌伴异位促肾上腺皮质激素综合征1例[J].临床荟萃,2013,28(4):449-450.
-
3谷琦琦,邱新光.甲状腺髓样癌的诊治进展[J].肿瘤基础与临床,2013,26(3):273-275. 被引量:9
-
4缪英杰,夏飞.甲状腺癌诊断与治疗研究新进展[J].中国临床研究,2014,27(3):356-358. 被引量:9
-
5郭林,王敏,卢仁泉.实验室检查在甲状腺结节诊治中的作用[J].中国普外基础与临床杂志,2014,21(9):1056-1060. 被引量:2
-
6李爽,李茉,王森,丁国楠,刘洋,姜瑛.甲状腺髓样癌诊断的研究进展[J].中国实验诊断学,2014,18(11):1902-1904. 被引量:3
-
7邢进,郭京.甲状腺髓样癌的外科治疗进展[J].大连医科大学学报,2015,37(1):93-96. 被引量:5
-
8王莉,张仲男,秦三利.1例以癌胚抗原升高首次发现的甲状腺髓样癌的诊治及文献复习[J].甘肃医药,2015,34(9):702-705.
-
9曹庆生,杨宝友,李志超.联合检测CT、CEA对术中诊断甲状腺髓样癌的意义[J].现代肿瘤医学,2016,24(1):36-39. 被引量:10
-
10孙建锋.实时超声弹性成像在甲状腺乳头状癌诊断中的应用价值[J].分子影像学杂志,2016,39(4):356-358. 被引量:2
-
1代琳,林胜友.甲状腺髓样癌1例临床分析[J].深圳中西医结合杂志,2010,20(6):395-396.
-
2王晓雷,徐震纲.甲状腺癌复发与转移的处理[J].中国医刊,2007,42(6):11-14. 被引量:4
-
3王正平,胡正彪,黄必飞.甲状腺髓样癌11例超声图像特征分析[J].浙江医学,2009,31(9):1318-1319.
-
4孙海军,郑立春.13例甲状腺髓样癌的CT表现分析[J].河北医科大学学报,2015,36(7):856-857. 被引量:4
-
5陈雨信,曾庆东.甲状腺癌的内分泌治疗[J].临床外科杂志,2006,14(3):179-180. 被引量:3
-
6赵自然,康维明.甲状腺髓样癌外科诊治[J].中华临床医师杂志(电子版),2012,6(5):126-129. 被引量:7
-
7孟翔凌.13例甲状腺髓样癌临床分析[J].医师进修杂志,1996,19(3):17-18.
-
8吴毅,许良中,沈强,黄彩平,王卓颖,朱伟萍.分化性甲状腺癌组织中p53基因蛋白表达及临床意义[J].中国癌症杂志,1997,7(4):267-269. 被引量:1
-
9吕庆杰,马颖,张锦华,李晓晗,王晓松,姜卫国.神经母细胞瘤P-gp和MRP的表达及预后因素分析[J].中国肿瘤临床,2002,29(12):850-854. 被引量:1
-
10侯亚莉,段秀英.卵巢未成熟畸胎瘤伴神经胶质种植转移3例临床病理分析[J].诊断病理学杂志,2003,10(2):78-80. 被引量:9